InvestorsObserver
×
News Home

Where Does Rocket Pharmaceuticals Inc (RCKT) Stock Fall in the Biotechnology Field After It Is Higher By 2.28% This Week?

Monday, November 27, 2023 11:52 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Rocket Pharmaceuticals Inc (RCKT) Stock Fall in the Biotechnology Field After It Is Higher By 2.28% This Week?

The 85 rating InvestorsObserver gives to Rocket Pharmaceuticals Inc (RCKT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 98 percent of stocks in the Biotechnology industry, RCKT’s 85 overall rating means the stock scores better than 85 percent of all stocks.

Overall Score - 85
RCKT has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on RCKT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 85 would rank higher than 85 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rocket Pharmaceuticals Inc Stock Today?

Rocket Pharmaceuticals Inc (RCKT) stock has gained 0.9% while the S&P 500 is down -0.12% as of 11:47 AM on Monday, Nov 27. RCKT has risen $0.20 from the previous closing price of $22.25 on volume of 81,250 shares. Over the past year the S&P 500 is higher by 14.89% while RCKT has risen 28.07%. RCKT lost -$3.17 per share the over the last 12 months. Click Here to get the full Stock Report for Rocket Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App